Tradestie Institutional Equity Comparison Engine
FXD vs FXH โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
FXH Overall Edge
FXH Captures Institutional Edge (2โ0 Pillars ยท 3โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to First Trust Health Care AlphaDEX Fund (FXH) driven by superior Momentum & Technical, Options & Structure. Fundamentally, FXD trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus FXH at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, FXD sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against FXH sits in UNCLASSIFIED (85th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
FXD N/M vs FXH N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
FXH
1Y +6.1% vs +21.8% ยท 52W Pos 67% vs 82%
Options & Structure Winner
FXH
UNCLASSIFIED (100th %ile IV) vs UNCLASSIFIED (85th %ile IV)
FXD
NYSE Arca
First Trust Consumer Discretionary AlphaDEX Fund
Institutional Equity
$69.86
-0.99% 1D
Market Cap
N/A
1M Return
+4.89%
1Y Return
+6.13%
Forward P/E
N/M
Unified AI Score
40.7 / 100
SELL
Tech 37.0
Fund 41.0
Flow 50.0
Mom 41.1
FXH
NYSE Arca
First Trust Health Care AlphaDEX Fund
Institutional Equity
$136.68
-1.11% 1D
Market Cap
N/A
1M Return
+3.21%
1Y Return
+21.77%
Forward P/E
N/M
Unified AI Score
48.7 / 100
HOLD
Tech 42.0
Fund 44.0
Flow 50.0
Mom 31.1
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
FXD +6.13%
FXH +21.77%
Spread: +15.64 pp (FXH Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
FXD TTM Op. Margin: N/A
FXH TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FXD vs FXH. Trailing 12-month operating profitability (FXD N/A vs FXH N/A) and valuation multiples (FXD N/M vs FXH N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | FXD | FXH | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 67% ($62โ$74) | 82% ($105โ$144) | Stronger Trend | FXH |
| Beta / 30D Volatility Risk Regime | 0.76ฮฒ ยท 33% Vol | 0.57ฮฒ ยท 25% Vol | Lower Realized Risk | FXH |
| Unified Institutional Score Composite Signal | 40.7 / 100 (SELL) | 48.7 / 100 (HOLD) | Higher Composite | FXH |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full FXD vs FXH Buy Guide
FXD
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
100th %ile
IV Regime
Extreme (>80th %ile)
FXH
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
85th %ile
IV Regime
Extreme (>80th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither FXD nor FXH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.